Does enhanced HIV prevention, diagnosis, and linkage to care reduce hospitalisation in high HIV-burden communities in Zambia and South Africa? findings from the HPTN 071 (PopART) randomised trial
Authors
Lawrence Mwenge (ORCID: https://orcid.org/0000-0002-8588-8939)
Peter Bock (ORCID: https://orcid.org/0000-0003-3211-6078)
National Institute of Allergy and Infectious Diseases
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Does enhanced HIV prevention, diagnosis, and linkage to care reduce hospitalisation in high HIV-burden communities in Zambia and South Africa? findings from the HPTN 071 (PopART) randomised trial
Lawrence Mwenge, Peter Bock, Katharina Hauck, Ranjeeta Thomas et al.
Journal
PLOS Global Public Health
Topics
HIV/AIDS Research and Interventions
article
Does enhanced HIV prevention, diagnosis, and linkage to care reduce hospitalisation in high HIV-burden communities in Zambia and South Africa? findings from the HPTN 071 (PopART) randomised trial
Lawrence Mwenge, Peter Bock, Katharina Hauck, Ranjeeta Thomas, S. Richardson, Abigail Harper, Helen Ayles, Nomtha Bell‐Mandla, Sarah Kanema, Ethan Wilson, Sarah Fidler, Sian Floyd, Ronelle Burger, Richard Hayes
article en
Abstract
No abstract available for this paper.
Publication Tag
PLOS Global Public HealthVol. 5(5)
Institutions
Desmond Tutu HIV Foundation (ZA), Stellenbosch University (ZA), University Teaching Hospital (ZM), University of Zambia (ZM), Public Health England (GB), Fred Hutch Cancer Center (US), London School of Hygiene & Tropical Medicine (GB), National HIV/AIDS/STI/TB Council (ZM), Imperial College London (GB), London School of Economics and Political Science (GB), Erasmus University Rotterdam (NL)
Funders
Bill and Melinda Gates Foundation, U.S. President’s Emergency Plan for AIDS Relief, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases